Andrew J Morris

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. ncbi Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation
    Andrew J Morris
    The Gill Heart Institute, University of Kentucky College of Medicine, Lexington, KY 40536, USA
    Trends Cardiovasc Med 19:135-40. 2009
  2. ncbi Therapeutic potential of autotaxin/lysophospholipase d inhibitors
    Lorenzo Federico
    Division of Cardiovascular Medicine, The Gill Heart Institute, 900 S Limestone Street, 326 CTW Building, Lexington, KY 40536 0200, USA
    Curr Drug Targets 9:698-708. 2008
  3. ncbi Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling
    Hsin Yuan Cheng
    Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY, USA
    Arterioscler Thromb Vasc Biol 32:24-32. 2012
  4. ncbi Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis
    Zehra Pamuklar
    Division of Cardiovascular Medicine, The Gill Heart Institute, Lexington, Kentucky 40536 0200, USA
    J Biol Chem 284:7385-94. 2009
  5. ncbi Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells
    ZACHARY FULKERSON
    Division of Cardiovascular Medicine, The Gill Heart Institute, Lexington, KY 40536 0200, USA
    J Biol Chem 286:34654-63. 2011
  6. ncbi Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions
    Samy Selim
    Division of Cardiovascular Medicine, The Gill Heart Institute, 741 S Limestone Street, Lexington, KY 40536 0509, USA
    Clin Sci (Lond) 121:565-72. 2011
  7. ncbi Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by beta3 integrin signaling
    Manikandan Panchatcharam
    Division of Cardiovascular Medicine, The Gill Heart Institute, University of Kentucky, Lexington, KY 40536 0200, United States
    Int J Biochem Cell Biol 42:965-74. 2010
  8. ncbi Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure
    Manikandan Panchatcharam
    Division of Cardiovascular Medicine, The Gill Heart Institute, Lexington, KY 40536, USA
    Circ Res 103:662-70. 2008
  9. ncbi Roles of lysophosphatidic acid in cardiovascular physiology and disease
    Susan S Smyth
    Department of Veterans Affairs Medical Center, Lexington, Kentucky 40511, USA
    Biochim Biophys Acta 1781:563-70. 2008
  10. ncbi A phosphatidic acid binding/nuclear localization motif determines lipin1 function in lipid metabolism and adipogenesis
    Hongmei Ren
    Division of Cardiovascular Medicine, The Gill Heart Institute, University of Kentucky, Lexington, KY 40536 0200, USA
    Mol Biol Cell 21:3171-81. 2010

Research Grants

Collaborators

Detail Information

Publications22

  1. ncbi Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation
    Andrew J Morris
    The Gill Heart Institute, University of Kentucky College of Medicine, Lexington, KY 40536, USA
    Trends Cardiovasc Med 19:135-40. 2009
    ..We review the mechanisms controlling the production, metabolism, and distribution of these lipids between vascular cells, circulating blood components, and the plasma...
  2. ncbi Therapeutic potential of autotaxin/lysophospholipase d inhibitors
    Lorenzo Federico
    Division of Cardiovascular Medicine, The Gill Heart Institute, 900 S Limestone Street, 326 CTW Building, Lexington, KY 40536 0200, USA
    Curr Drug Targets 9:698-708. 2008
    ....
  3. ncbi Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling
    Hsin Yuan Cheng
    Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY, USA
    Arterioscler Thromb Vasc Biol 32:24-32. 2012
    ..To determine whether LPA contributes to remodeling of the pulmonary vasculature, we examined responses in mice with alterations in LPA signaling and metabolism...
  4. ncbi Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis
    Zehra Pamuklar
    Division of Cardiovascular Medicine, The Gill Heart Institute, Lexington, Kentucky 40536 0200, USA
    J Biol Chem 284:7385-94. 2009
    ....
  5. ncbi Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells
    ZACHARY FULKERSON
    Division of Cardiovascular Medicine, The Gill Heart Institute, Lexington, KY 40536 0200, USA
    J Biol Chem 286:34654-63. 2011
    ..Integrin binding therefore localizes ATX activity to the cell surface, providing a mechanism to generate LPA in the vicinity of its receptors...
  6. ncbi Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions
    Samy Selim
    Division of Cardiovascular Medicine, The Gill Heart Institute, 741 S Limestone Street, Lexington, KY 40536 0509, USA
    Clin Sci (Lond) 121:565-72. 2011
    ..Changes in S1P content may contribute to an RBC storage lesion. Further studies should investigate the clinical significance of alterations in circulating S1P levels and the potential value of enriching stored RBCs with S1P...
  7. ncbi Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by beta3 integrin signaling
    Manikandan Panchatcharam
    Division of Cardiovascular Medicine, The Gill Heart Institute, University of Kentucky, Lexington, KY 40536 0200, United States
    Int J Biochem Cell Biol 42:965-74. 2010
    ....
  8. ncbi Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure
    Manikandan Panchatcharam
    Division of Cardiovascular Medicine, The Gill Heart Institute, Lexington, KY 40536, USA
    Circ Res 103:662-70. 2008
    ..These results identify a role for LPA1 and LPA2 in regulating SMC migratory responses in the context of vascular injury but suggest that additional LPA receptor subtypes are required for other LPA-mediated effects in the vasculature...
  9. ncbi Roles of lysophosphatidic acid in cardiovascular physiology and disease
    Susan S Smyth
    Department of Veterans Affairs Medical Center, Lexington, Kentucky 40511, USA
    Biochim Biophys Acta 1781:563-70. 2008
    ..In this review we discuss aspects of LPA signaling in the cardiovasculature focusing on recent advances and attempting to highlight presently unresolved issues and promising avenues for further investigation...
  10. ncbi A phosphatidic acid binding/nuclear localization motif determines lipin1 function in lipid metabolism and adipogenesis
    Hongmei Ren
    Division of Cardiovascular Medicine, The Gill Heart Institute, University of Kentucky, Lexington, KY 40536 0200, USA
    Mol Biol Cell 21:3171-81. 2010
    ..These two functions are necessary for full expression of the biological activity of the protein in intracellular lipid metabolism and transcriptional control of adipogenesis...
  11. ncbi Bioactive products generated by group V sPLA(2) hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines
    Boris B Boyanovsky
    Department of Internal Medicine Endocrinology Division, University of Kentucky, Lexington, 40536, USA
    Cytokine 50:50-7. 2010
    ..The aim of the present study was to determine whether GV sPLA(2)-hydrolyzed LDL (GV-LDL) produces pro-atherogenic effects in macrophages independent of cholesterol accumulation...
  12. ncbi Functional characterization of the atypical integral membrane lipid phosphatase PDP1/PPAPDC2 identifies a pathway for interconversion of isoprenols and isoprenoid phosphates in mammalian cells
    Sumitra Miriyala
    Division of Cardiovascular Medicine, The Gill Heart Institute, University of Kentucky, Lexington, Kentucky 40536 0200, USA
    J Biol Chem 285:13918-29. 2010
    ..Taken together, these results focus attention on integral membrane lipid phosphatases as regulators of isoprenoid phosphate metabolism and suggest that PDP1/PPAPDC2 is a functional isoprenoid diphosphate phosphatase...
  13. ncbi Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway
    Zehra Pamuklar
    Division of Cardiovascular Medicine, The Gill Heart Institute, University of Kentucky, Lexington, KY 40536, USA
    Arterioscler Thromb Vasc Biol 28:555-61. 2008
    ..LPA is present in blood and exposure or release of LPA after atherosclerotic plaque rupture has been proposed to trigger platelet thrombus formation...
  14. ncbi Measurement of autotaxin/lysophospholipase D activity
    Andrew J Morris
    Division of Cardiovascular Medicine, The Gill Heart Institute, University of Kentucky College of Medicine, Lexington, Kentucky, USA
    Methods Enzymol 434:89-104. 2007
    ..This chapter describes methods for determining the activity of recombinant autotaxin/lysoPLD using radiolabeled and fluorogenic substrates...
  15. ncbi Omega-3 fatty acid oxidation products prevent vascular endothelial cell activation by coplanar polychlorinated biphenyls
    Zuzana Majkova
    Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40536 0200, USA
    Toxicol Appl Pharmacol 251:41-9. 2011
    ..Our data implicate A?/J?-NPs as mediators of omega-3 fatty acid-mediated protection against the endothelial toxicity of coplanar PCBs...
  16. ncbi Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer
    Janos L Tanyi
    Departments of Molecular Therapeutics, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 9:3534-45. 2003
    ..Thus, the LPA-rich environment of the ovarian cancer cell in vivo and the subsequent effects of cellular pathophysiology may be a consequence of both increased LPA production and decreased LPA metabolism by ovarian cancer cells...
  17. ncbi Is PRG-1 a new lipid phosphatase?
    Mark I McDermott
    Nat Neurosci 7:789; author reply 789-90. 2004
  18. ncbi Enzymatic analysis of lipid phosphate phosphatases
    Mark I McDermott
    Departments of Medicine and Cellular and Molecular Biochemistry, Gill Heart Institute, 900 South Limestone Street 326 Charles T. Wethington Building, Lexington KY 40536, USA
    Methods 39:169-79. 2006
    ..We describe the use of both radiolabeled and fluorescent lipid substrates for the detection, quantitation and analysis of the enzymatic activities of the LPPs measured using intact or broken cell preparations as the source of enzyme...
  19. ncbi Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity
    Susan S Smyth
    Howard Hughes Medical Institute, University of California, San Diego, La Jolla, California 92093 0668, USA
    J Biol Chem 278:43214-23. 2003
    ....
  20. ncbi Lysophosphatidic acid signaling: how a small lipid does big things
    Celine Luquain
    Department of Cell and Developmental Biology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27699-7090, USA
    Trends Biochem Sci 28:377-83. 2003
  21. ncbi Role of phospholipase D in agonist-stimulated lysophosphatidic acid synthesis by ovarian cancer cells
    Celine Luquain
    Department of Cell and Developmental Biology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599 7090, USA
    J Lipid Res 44:1963-75. 2003
    ..Our results identify a novel role for nucleotides in the regulation of ovarian cancer cells and suggest an indirect but critical function for PLD2 in agonist-stimulated LPA production...
  22. ncbi The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer
    Janos L Tanyi
    Department of Molecular Therapeutics, University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Res 63:1073-82. 2003
    ..Thus genetic or pharmacological manipulation of LPA metabolism, receptor activation, or downstream signaling is an attractive approach for therapy of ovarian cancer...

Research Grants26

  1. FASEB SUMMER RESEARCH CONFERENCE: BIOACTIVE LYSOLIPIDS
    Andrew Morris; Fiscal Year: 2005
    ..abstract_text> ..
  2. Lysophospholipid Mediators in Ovarian Cancer
    Andrew Morris; Fiscal Year: 2005
    ..Successful completion of the research will provide the framework and impetus to develop novel effective therapeutics for ovarian cancer. ..
  3. Lysophosphatidic Acid: Synthesis, Actions & Inactivation
    Andrew Morris; Fiscal Year: 2007
    ..Resolution of the interrelated issues outlined above is central to this goal because it will ultimately lead to the design of pharmacological and genetic strategies to manipulate LPA signaling in vivo. ..
  4. Role of Lipid Phosphatases in Cholesterol and Triglyceride Synthesis
    Andrew J Morris; Fiscal Year: 2010
    ....
  5. FASEB SUMMER CONFERENCE ON PHOSPHOLIPASES
    Andrew Morris; Fiscal Year: 2004
    ..For the past 10 years this field has generated about 2000 peer reviewed research publications each year. The funds requested in this proposal will make an invaluable contribution to the support of this conference. ..
  6. PHOSPHATIDYLCHOLINE SIGNALING
    Andrew Morris; Fiscal Year: 2003
    ..abstract_text> ..
  7. Role of Lipid Phosphatases in Cholesterol and Triglyceride Synthesis
    Andrew J Morris; Fiscal Year: 2010
    ....